I help results-oriented investors position their healthcare technology assets for sale

Rapid delivery of sophisticated, diligence-ready CIMs and equity stories


A sampling of the national healthcare brands I've worked with consistently for the last 25 years:

I don’t just package companies for sale — I shape how investors understand them.

Gain a sophisticated, investor-grade equity story when you hand CIM development to an expert who crafts CIMs that command double-digit variables.

Leveraging 25 years of enterprise narrative expertise, including two decades leading marketing at McKesson and Availity, I equip teams with CIMs and equity stories that are clear, convincing, and ready for diligence. And because the healthcare technology learning curve is already built in, the diligence processes advance without delay.

I'm a former healthcare technology CMO with first-hand experience scaling platforms.

Far in advance of the process and as an ally to their sales and marketing teams, I will engage directly with the portfolio company’s growth leaders and provide actionable recommendations designed to support and strengthen the future diligence story.

I'm focused on the CIM, so you can focus on shopping the asset.

I support private equity firms and the healthcare technology growth teams who are preparing for an investment or exit event. By taking development of the CIM, equity story, or enterprise narrative off the shoulders of internal marketing leaders, they will be able to focus all of their energy on growing your asset. Meanwhile, your narrative will be in the hands of a healthcare technology storyteller who will prioritize this work above all else.

About Us

DID YOU KNOW...

MOST HEALTHCARE TECHNOLOGY companies wait too long to transform their enterprise narratives into ones that will hold up as equity stories. Most (if not all) companies won't begin drafting their equity stories until they're actively preparing for recapitalization events. By waiting until the time of recap to write the equity story, key parts will ring hollow because they aren’t reinforced in customer perceptions or diligence conversations. As a result, the buyer's interviews with clients and stakeholders won’t validate the company’s claims, leaving the buyer skeptical and valuation multiples at risk.

Would you like to learn other simple tips for improving the quality of your healthcare technology CIMs?

I offer a COMPLIMENTARY 60-MINUTE EQUITY STORY APPRAISAL. No commitment required.

Reach out for more information:  

Free Equity Story Appraisal